Molecular biology of pancreatic neuroendocrine tumors: From mechanism to translation
Open Access
- 28 September 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12
Abstract
Pancreatic neuroendocrine tumors (pNETs) are a group of heterogeneous tumors originated from progenitor cells. As these tumors are predominantly non-functional, most of them display asymptomatic characteristics, making it difficult to be realized from early onset. Therefore, patients with pNETs are usually diagnosed with metastatic disease or at a late disease stage. The relatively low incidence also limits our understanding of the biological background of pNETs, which largely impair the development of new effective drugs. The fact that up to 10% of pNETs develop in patients with genetic syndromes have promoted researchers to focus on the gene mutations and driver mutations in MEN1, DAXX/ATRX and mTOR signaling pathway genes have been implicated in disease development and progression. Recent advances in sequencing technologies have further enriched our knowledge of the complex molecular landscape of pNETs, pointing out crucial roles of genes in DNA damage pathways, chromosomal and telomere alterations and epigenetic dysregulation. These novel findings may not only benefit early diagnosis of pNETs, but also help to uncover tumor heterogeneity and shape the future of translational medical treatment. In this review, we focus on the current molecular biology of pNETs and decipher how these findings may translate into future development of targeted therapy.Keywords
Funding Information
- National Natural Science Foundation of China (82172645, 81970500, 81802846)
- Natural Science Foundation of Jiangsu Province
This publication has 84 references indexed in Scilit:
- Menin mediates epigenetic regulation via histone H3 lysine 9 methylationCell Death & Disease, 2013
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primariesAnnals of Oncology, 2011
- Regulation of Cyclin B2 Expression and Cell Cycle G2/M Transition by MeninJournal of Biological Chemistry, 2010
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasisNature, 2010
- Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic RegionsCell, 2010
- Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor InitiationMolecular Cell, 2009
- Menin interacts with IQGAP1 to enhance intercellular adhesion of β-cellsOncogene, 2008
- Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversiesCancer, 2008
- Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors)Laboratory Investigation, 2007